Bagdasaryan, A.A.; Chubarev, V.N.; Smolyarchuk, E.A.; Drozdov, V.N.; Krasnyuk, I.I.; Liu, J.; Fan, R.; Tse, E.; Shikh, E.V.; Sukocheva, O.A.
Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy. Cancers 2022, 14, 5436.
https://doi.org/10.3390/cancers14215436
AMA Style
Bagdasaryan AA, Chubarev VN, Smolyarchuk EA, Drozdov VN, Krasnyuk II, Liu J, Fan R, Tse E, Shikh EV, Sukocheva OA.
Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy. Cancers. 2022; 14(21):5436.
https://doi.org/10.3390/cancers14215436
Chicago/Turabian Style
Bagdasaryan, Alina A., Vladimir N. Chubarev, Elena A. Smolyarchuk, Vladimir N. Drozdov, Ivan I. Krasnyuk, Junqi Liu, Ruitai Fan, Edmund Tse, Evgenia V. Shikh, and Olga A. Sukocheva.
2022. "Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy" Cancers 14, no. 21: 5436.
https://doi.org/10.3390/cancers14215436
APA Style
Bagdasaryan, A. A., Chubarev, V. N., Smolyarchuk, E. A., Drozdov, V. N., Krasnyuk, I. I., Liu, J., Fan, R., Tse, E., Shikh, E. V., & Sukocheva, O. A.
(2022). Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy. Cancers, 14(21), 5436.
https://doi.org/10.3390/cancers14215436